Metformin in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)
NCT00247117 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2006-10-09
Summary
The purpose of this study is to examine the effect of metformin on biochemical and histological findings in NAFLD patients with insulin resistance syndrome.
Conditions
Interventions
- DRUG
Sponsors & Collaborators
-
Kaplan Medical Center
lead OTHER
Principal Investigators
-
Stephen D Malnick, MD · Kaplan Medical Center
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-01-31
- Completion
- 2005-08-31
Countries
- Israel
Study Locations
More Related Trials
-
Antidiabetic Effects on Intrahepatic Fat
NCT03068065 ·Status: COMPLETED ·Phase: PHASE4
-
Metformin Therapy in Type 1 Diabetes Mellitus.
NCT01889706 ·Status: UNKNOWN
-
Metformin in Postmenopausal Women With Metabolic Syndrome
NCT01342744 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy Study of Metformin Glycinate on Postprandial Lipemia
NCT02064881 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Metformin in Overweight Type 2 Diabetes Mellitus
NCT00922194 ·Status: COMPLETED ·Phase: NA
-
Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo
NCT05949008 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease
NCT03459079 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Explore Pharmacokinetic Interaction Between Rilpivirine and Metformin in Healthy Participants
NCT01719614 ·Status: COMPLETED ·Phase: PHASE1
-
Study of PF 04965842 Effect on MATE1/2K Activity in Healthy Participants
NCT03796182 ·Status: COMPLETED ·Phase: PHASE1
-
Short-Term Glycemic Effects of Liquid Metformin vs Standard Tablets
NCT07300059 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Access the Efficacy in Type 2 Diabetes Mellitus on Stable Metformin
NCT04662164 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Drug-drug Interaction Study Between Daclatasvir and Metformin
NCT02565862 ·Status: COMPLETED ·Phase: PHASE1
-
Study On the Role of Mitochondrial Dysfunction in the Pathogenesis of Metformin-associated Lactic Acidosis
NCT00942123 ·Status: COMPLETED
-
"Hepatic Substrate Flux Rates in Type 2 Diabetes"
NCT04088851 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Metformin's Effect on Glucagon-induced Glucose Production and Protein Metabolism.
NCT01956929 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study of Metformin to Reduce Cerebrovascular Dysfunction in Participants With HIV and Metabolic Syndrome.
NCT05571319 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Food Effect on Bioavailability of Metformin/Gliclazide in Healthy Participants
NCT03467971 ·Status: COMPLETED ·Phase: PHASE1
-
Cardio-protective Effect of Metformin in Patients Undergoing PCI
NCT05708053 ·Status: UNKNOWN ·Phase: PHASE3
-
Pilot Study With GFT505 (80mg) in Patients With Insulin Resistance and Abdominal Obesity
NCT01271777 ·Status: COMPLETED ·Phase: PHASE2
-
Cancer Chemoprevention by Metformin Hydrochloride Compared to Placebo in Oral Potentially Malignant Lesions
NCT03684707 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM Patients
NCT01490918 ·Status: COMPLETED ·Phase: PHASE4
-
A Multiple Dose Investigational Drug Study in Patients With Type 2 Diabetes (MK-0941-005)
NCT00511667 ·Status: COMPLETED ·Phase: PHASE1
-
Metformin Glycinate on Metabolic Control and Inflammatory Mediators in Type 2 Diabetes
NCT01386671 ·Status: COMPLETED ·Phase: PHASE3
-
A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY
NCT04617275 ·Status: COMPLETED ·Phase: PHASE2
-
Metformin to Reduce Heart Failure After Myocardial Infarction
NCT01217307 ·Status: COMPLETED ·Phase: PHASE2/PHASE3